(4Z)-4-(2-amino-4-oxo-1H-imidazol-5-ylidene)-1,5,6,7-tetrahydropyrrolo[2,3-c]azepin-8-one
Internal ID | 1a59966d-2c41-4155-97a4-168873a18d92 |
Taxonomy | Organoheterocyclic compounds > Pyrroloazepines |
IUPAC Name | (4Z)-4-(2-amino-4-oxo-1H-imidazol-5-ylidene)-1,5,6,7-tetrahydropyrrolo[2,3-c]azepin-8-one |
SMILES (Canonical) | C1CNC(=O)C2=C(C1=C3C(=O)N=C(N3)N)C=CN2 |
SMILES (Isomeric) | C\1CNC(=O)C2=C(/C1=C\3/C(=O)N=C(N3)N)C=CN2 |
InChI | InChI=1S/C11H11N5O2/c12-11-15-8(10(18)16-11)6-2-4-14-9(17)7-5(6)1-3-13-7/h1,3,13H,2,4H2,(H,14,17)(H3,12,15,16,18)/b8-6- |
InChI Key | JYRJOQGKGMHTOO-VURMDHGXSA-N |
Popularity | 7 references in papers |
Molecular Formula | C11H11N5O2 |
Molecular Weight | 245.24 g/mol |
Exact Mass | 245.09127461 g/mol |
Topological Polar Surface Area (TPSA) | 112.00 Ų |
XlogP | -1.20 |
Atomic LogP (AlogP) | -0.70 |
H-Bond Acceptor | 4 |
H-Bond Donor | 4 |
Rotatable Bonds | 0 |
There are no found synonyms. |
![2D Structure of (4Z)-4-(2-amino-4-oxo-1H-imidazol-5-ylidene)-1,5,6,7-tetrahydropyrrolo[2,3-c]azepin-8-one 2D Structure of (4Z)-4-(2-amino-4-oxo-1H-imidazol-5-ylidene)-1,5,6,7-tetrahydropyrrolo[2,3-c]azepin-8-one](https://plantaedb.com/storage/docs/compounds/2023/07/4z-4-2-amino-4-oxo-1h-imidazol-5-ylidene-1567-tetrahydropyrrolo23-cazepin-8-one.jpg)
Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.9888 | 98.88% |
Caco-2 | - | 0.6552 | 65.52% |
Blood Brain Barrier | + | 0.5750 | 57.50% |
Human oral bioavailability | + | 0.7000 | 70.00% |
Subcellular localzation | Mitochondria | 0.4890 | 48.90% |
OATP2B1 inhibitior | - | 1.0000 | 100.00% |
OATP1B1 inhibitior | + | 0.9575 | 95.75% |
OATP1B3 inhibitior | + | 0.9406 | 94.06% |
MATE1 inhibitior | - | 0.6000 | 60.00% |
OCT2 inhibitior | - | 0.6500 | 65.00% |
BSEP inhibitior | - | 0.7847 | 78.47% |
P-glycoprotein inhibitior | - | 0.9485 | 94.85% |
P-glycoprotein substrate | - | 0.7216 | 72.16% |
CYP3A4 substrate | - | 0.5344 | 53.44% |
CYP2C9 substrate | - | 1.0000 | 100.00% |
CYP2D6 substrate | - | 0.8333 | 83.33% |
CYP3A4 inhibition | - | 0.7111 | 71.11% |
CYP2C9 inhibition | - | 0.7686 | 76.86% |
CYP2C19 inhibition | - | 0.6786 | 67.86% |
CYP2D6 inhibition | - | 0.8350 | 83.50% |
CYP1A2 inhibition | - | 0.5413 | 54.13% |
CYP2C8 inhibition | - | 0.8918 | 89.18% |
CYP inhibitory promiscuity | - | 0.9007 | 90.07% |
UGT catelyzed | - | 0.0000 | 0.00% |
Carcinogenicity (binary) | - | 0.8700 | 87.00% |
Carcinogenicity (trinary) | Non-required | 0.5931 | 59.31% |
Eye corrosion | - | 0.9823 | 98.23% |
Eye irritation | - | 0.9924 | 99.24% |
Skin irritation | - | 0.7726 | 77.26% |
Skin corrosion | - | 0.9214 | 92.14% |
Ames mutagenesis | + | 0.5400 | 54.00% |
Human Ether-a-go-go-Related Gene inhibition | - | 0.6624 | 66.24% |
Micronuclear | + | 0.7800 | 78.00% |
Hepatotoxicity | + | 0.6500 | 65.00% |
skin sensitisation | - | 0.8411 | 84.11% |
Respiratory toxicity | + | 0.7111 | 71.11% |
Reproductive toxicity | + | 0.8444 | 84.44% |
Mitochondrial toxicity | + | 0.8875 | 88.75% |
Nephrotoxicity | - | 0.6602 | 66.02% |
Acute Oral Toxicity (c) | III | 0.5682 | 56.82% |
Estrogen receptor binding | - | 0.4816 | 48.16% |
Androgen receptor binding | + | 0.5604 | 56.04% |
Thyroid receptor binding | + | 0.6465 | 64.65% |
Glucocorticoid receptor binding | + | 0.6784 | 67.84% |
Aromatase binding | + | 0.7463 | 74.63% |
PPAR gamma | - | 0.5559 | 55.59% |
Honey bee toxicity | - | 0.8094 | 80.94% |
Biodegradation | - | 0.8750 | 87.50% |
Crustacea aquatic toxicity | - | 0.5500 | 55.00% |
Fish aquatic toxicity | - | 0.7550 | 75.50% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
CHEMBL3587 | Q02750 | Dual specificity mitogen-activated protein kinase kinase 1 |
2500 nM |
IC50 |
PMID: 11784156
|
CHEMBL4040 | P28482 | MAP kinase ERK2 |
824 nM 824 nM |
IC50 IC50 |
PMID: 11784156
PMID: 15261294 |
CHEMBL4630 | O14757 | Serine/threonine-protein kinase Chk1 |
725 nM 330 nM 725 nM |
IC50 IC50 IC50 |
PMID: 22285028
PMID: 19111462 PMID: 15261294 |
CHEMBL2527 | O96017 | Serine/threonine-protein kinase Chk2 |
183 nM 183 nM |
IC50 IC50 |
PMID: 22285028
PMID: 15261294 |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 91.36% | 96.09% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 91.17% | 91.11% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 91.14% | 94.45% |
CHEMBL3384 | Q16512 | Protein kinase N1 | 90.93% | 80.71% |
CHEMBL4224 | P49759 | Dual specificty protein kinase CLK1 | 90.15% | 85.30% |
CHEMBL2581 | P07339 | Cathepsin D | 88.54% | 98.95% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 88.32% | 95.56% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 86.97% | 97.09% |
CHEMBL2094127 | P06493 | Cyclin-dependent kinase 1/cyclin B | 86.12% | 96.00% |
CHEMBL2635 | P51452 | Dual specificity protein phosphatase 3 | 84.93% | 94.00% |
CHEMBL4225 | P49760 | Dual specificity protein kinase CLK2 | 84.44% | 80.96% |
CHEMBL4208 | P20618 | Proteasome component C5 | 83.76% | 90.00% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 82.22% | 86.33% |
CHEMBL255 | P29275 | Adenosine A2b receptor | 81.83% | 98.59% |
CHEMBL2996 | Q05655 | Protein kinase C delta | 81.68% | 97.79% |
CHEMBL2378 | P30307 | Dual specificity phosphatase Cdc25C | 81.37% | 96.67% |
CHEMBL262 | P49841 | Glycogen synthase kinase-3 beta | 80.82% | 95.72% |
CHEMBL2345 | P51812 | Ribosomal protein S6 kinase alpha 3 | 80.72% | 95.64% |
CHEMBL2850 | P49840 | Glycogen synthase kinase-3 alpha | 80.57% | 88.84% |
CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 80.52% | 83.10% |
CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 80.30% | 92.88% |
CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 80.26% | 82.86% |
CHEMBL226 | P30542 | Adenosine A1 receptor | 80.25% | 95.93% |
CHEMBL299 | P17252 | Protein kinase C alpha | 80.08% | 98.03% |
CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 80.02% | 95.89% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Leiboldia serrata |
Marah fabacea |
PubChem | 5288032 |
NPASS | NPC162268 |
ChEMBL | CHEMBL255465 |
LOTUS | LTS0076073 |
wikiData | Q105192744 |